Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
Newsletter
The Competitive Enterprise Institute Daily Update
1. REGULATION Washington Post columnist Cindy Skrzycki cites CEI’s most recent regulatory study, Ten Thousand Commandments. CEI Expert Available to Comment:…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. GLOBAL WARMING The Bush Administration’s position on global warming is affirmed at the G8…
Op-Eds
Trillion-Dollar Radiation Mistake?, by Steven Milloy
A federal research panel last week concluded that there is no safe exposure to radiation. It’s a conclusion based on assumptions about cancer…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. INTERNATIONAL DEVELOPMENT The G8 nations propose a new aid package for Africa. CEI Expert Available…
Op-Eds
The UN at 60, by Henry Miller and Gregory Conko
The United Nations, now celebrating the sixtieth anniversary of the signing of its charter, is not aging well. Its officials are being accused…
Newsletter
The Competitive Enterprise Institute Daily Update
Issues in the News 1. INTERNATIONAL DEVELOPMENT Politicians and economic experts from around the world gather in Scotland this week for…